SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001213900-22-058423
Filing Date
2022-09-23
Accepted
2022-09-23 16:30:47
Documents
6

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea166039-f3_altamiratherap.htm F-3 167863
2 OPINION OF CONYERS DILL & PEARMAN LIMITED, SPECIAL BERMUDA COUNSEL TO THE COMPAN ea166039ex5-1_altamira.htm EX-5.1 24143
3 CONSENT OF DELOITTE AG ea166039ex23-2_altamira.htm EX-23.2 2387
4 FILING FEE TABLE ea166039ex-fee_altamira.htm EX-FILING FEES 48211
5 GRAPHIC image_001.jpg GRAPHIC 13368
6 GRAPHIC ex5-1_001.jpg GRAPHIC 3987
  Complete submission text file 0001213900-22-058423.txt   268096
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94
Altamira Therapeutics Ltd. (Filer) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-267584 | Film No.: 221262673
SIC: 2834 Pharmaceutical Preparations